Torque Presents Preclinical Data at AACR Demonstrating that Deep-Primed IL-15 and Deep-Primed IL-12 Anchored to T Cells are Superior to Systemically Administered IL-15 and IL-12 for Increasing T Cell Infiltration and Tumor Killing Without Systemic Toxicity
PhoreMost, a biopharmaceutical company dedicated to drugging 'undruggable' disease targets, has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.
Thermo Fisher Scientific is launching five new solutions in instrumentation, data management, sample preparation and consumables at Analytica 2018 (Messe MÃ¼nchen, booth 101, hall B1) in Munich, Germany.
This collaboration will utilize Protagenâs SeroTag technology to help identify biomarkers that predict and monitor immune-related adverse events (irAEs) in cancer patients treated with checkpoint inhibitors.
Ubiquigent Limited announced that it has entered into a multi-year strategic R&D collaboration agreement with FORMA Therapeutics for the design and development of novel deubiquitylase (DUB) enzyme inhibitors.
IONTAS Limited, a leader in the discovery and optimisation of fully human antibodies, announced that it will collaborate with IGEM Therapeutics, an immuno-oncology company developing novel IgE antibodies to treat cancer.